nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—CYP1A1—breast cancer	0.126	0.42	CbGaD
Ticlopidine—CYP2D6—breast cancer	0.0937	0.312	CbGaD
Ticlopidine—CYP3A4—breast cancer	0.0803	0.268	CbGaD
Ticlopidine—CYP1A1—Toremifene—breast cancer	0.0387	0.0825	CbGbCtD
Ticlopidine—MPO—Carboplatin—breast cancer	0.0355	0.0757	CbGbCtD
Ticlopidine—CYP2B6—Thiotepa—breast cancer	0.0244	0.0521	CbGbCtD
Ticlopidine—CYP1A2—Anastrozole—breast cancer	0.0189	0.0403	CbGbCtD
Ticlopidine—CYP1A2—Toremifene—breast cancer	0.0173	0.0368	CbGbCtD
Ticlopidine—CYP2C9—Anastrozole—breast cancer	0.017	0.0363	CbGbCtD
Ticlopidine—CYP2B6—Raloxifene—breast cancer	0.0163	0.0347	CbGbCtD
Ticlopidine—CYP2C8—Lapatinib—breast cancer	0.0163	0.0347	CbGbCtD
Ticlopidine—CYP1A1—Tamoxifen—breast cancer	0.0141	0.0301	CbGbCtD
Ticlopidine—CYP2C19—Lapatinib—breast cancer	0.0137	0.0291	CbGbCtD
Ticlopidine—CYP3A4—Exemestane—breast cancer	0.0131	0.0278	CbGbCtD
Ticlopidine—CYP2C9—Idarubicin—breast cancer	0.0129	0.0275	CbGbCtD
Ticlopidine—CYP2C8—Raloxifene—breast cancer	0.0123	0.0263	CbGbCtD
Ticlopidine—CYP2D6—Idarubicin—breast cancer	0.0118	0.0252	CbGbCtD
Ticlopidine—CYP3A4—Letrozole—breast cancer	0.0111	0.0237	CbGbCtD
Ticlopidine—CYP2E1—Tamoxifen—breast cancer	0.0109	0.0233	CbGbCtD
Ticlopidine—CYP2B6—Tamoxifen—breast cancer	0.0108	0.023	CbGbCtD
Ticlopidine—CYP2E1—Mitoxantrone—breast cancer	0.0106	0.0227	CbGbCtD
Ticlopidine—CYP3A4—Anastrozole—breast cancer	0.0099	0.0211	CbGbCtD
Ticlopidine—CYP3A4—Toremifene—breast cancer	0.00905	0.0193	CbGbCtD
Ticlopidine—CYP3A4—Fulvestrant—breast cancer	0.00842	0.0179	CbGbCtD
Ticlopidine—CYP2B6—Irinotecan—breast cancer	0.00827	0.0176	CbGbCtD
Ticlopidine—CYP2C8—Tamoxifen—breast cancer	0.00815	0.0174	CbGbCtD
Ticlopidine—CYP3A4—Thiotepa—breast cancer	0.0075	0.016	CbGbCtD
Ticlopidine—CYP2C9—Capecitabine—breast cancer	0.00707	0.0151	CbGbCtD
Ticlopidine—CYP3A4—Ixabepilone—breast cancer	0.00686	0.0146	CbGbCtD
Ticlopidine—CYP2C19—Tamoxifen—breast cancer	0.00684	0.0146	CbGbCtD
Ticlopidine—CYP3A4—Lapatinib—breast cancer	0.0066	0.0141	CbGbCtD
Ticlopidine—CYP2C8—Paclitaxel—breast cancer	0.00635	0.0135	CbGbCtD
Ticlopidine—CYP1A2—Tamoxifen—breast cancer	0.00631	0.0135	CbGbCtD
Ticlopidine—CYP2C8—Fluorouracil—breast cancer	0.00601	0.0128	CbGbCtD
Ticlopidine—CYP2D6—Vinorelbine—breast cancer	0.00576	0.0123	CbGbCtD
Ticlopidine—CYP2C9—Tamoxifen—breast cancer	0.00569	0.0121	CbGbCtD
Ticlopidine—CYP2D6—Tamoxifen—breast cancer	0.0052	0.0111	CbGbCtD
Ticlopidine—CYP3A4—Raloxifene—breast cancer	0.00501	0.0107	CbGbCtD
Ticlopidine—CYP1A2—Fluorouracil—breast cancer	0.00465	0.00992	CbGbCtD
Ticlopidine—CYP2B6—Doxorubicin—breast cancer	0.00452	0.00963	CbGbCtD
Ticlopidine—CYP2C9—Paclitaxel—breast cancer	0.00443	0.00944	CbGbCtD
Ticlopidine—CYP2C9—Fluorouracil—breast cancer	0.00419	0.00894	CbGbCtD
Ticlopidine—CYP3A4—Vinorelbine—breast cancer	0.00366	0.00781	CbGbCtD
Ticlopidine—CYP2D6—Vinblastine—breast cancer	0.00355	0.00757	CbGbCtD
Ticlopidine—CYP3A4—Tamoxifen—breast cancer	0.00331	0.00705	CbGbCtD
Ticlopidine—CYP3A4—Mitoxantrone—breast cancer	0.00323	0.00688	CbGbCtD
Ticlopidine—CYP3A4—Paclitaxel—breast cancer	0.00257	0.00549	CbGbCtD
Ticlopidine—CYP3A4—Irinotecan—breast cancer	0.00254	0.00541	CbGbCtD
Ticlopidine—CYP3A4—Vinblastine—breast cancer	0.00226	0.00481	CbGbCtD
Ticlopidine—CYP2D6—Doxorubicin—breast cancer	0.00218	0.00465	CbGbCtD
Ticlopidine—CYP3A4—Docetaxel—breast cancer	0.00186	0.00397	CbGbCtD
Ticlopidine—CYP3A4—Doxorubicin—breast cancer	0.00139	0.00296	CbGbCtD
Ticlopidine—P2RY12—epithelium—breast cancer	0.000752	0.0987	CbGeAlD
Ticlopidine—Clopidogrel—CYP3A4—breast cancer	0.000532	0.546	CrCbGaD
Ticlopidine—P2RY12—endocrine gland—breast cancer	0.000473	0.0621	CbGeAlD
Ticlopidine—Clopidogrel—ABCB1—breast cancer	0.000443	0.454	CrCbGaD
Ticlopidine—CYP2C8—mammary gland—breast cancer	0.000347	0.0455	CbGeAlD
Ticlopidine—MPO—epithelium—breast cancer	0.00033	0.0433	CbGeAlD
Ticlopidine—MPO—skin of body—breast cancer	0.000314	0.0412	CbGeAlD
Ticlopidine—CYP2C9—mammary gland—breast cancer	0.000308	0.0404	CbGeAlD
Ticlopidine—CYP1A2—nipple—breast cancer	0.000268	0.0352	CbGeAlD
Ticlopidine—MPO—pituitary gland—breast cancer	0.000268	0.0351	CbGeAlD
Ticlopidine—CYP1A1—nipple—breast cancer	0.000265	0.0347	CbGeAlD
Ticlopidine—MPO—adrenal gland—breast cancer	0.000239	0.0314	CbGeAlD
Ticlopidine—MPO—bone marrow—breast cancer	0.000231	0.0304	CbGeAlD
Ticlopidine—MPO—endocrine gland—breast cancer	0.000207	0.0272	CbGeAlD
Ticlopidine—CYP1A1—epithelium—breast cancer	0.000178	0.0234	CbGeAlD
Ticlopidine—CYP2C8—endometrium—breast cancer	0.000173	0.0227	CbGeAlD
Ticlopidine—CYP1A1—skin of body—breast cancer	0.000169	0.0222	CbGeAlD
Ticlopidine—CYP2B6—skin of body—breast cancer	0.000165	0.0216	CbGeAlD
Ticlopidine—CYP2C8—pituitary gland—breast cancer	0.000157	0.0206	CbGeAlD
Ticlopidine—CYP1A1—uterus—breast cancer	0.000147	0.0193	CbGeAlD
Ticlopidine—CYP1A1—adipose tissue—breast cancer	0.000144	0.0189	CbGeAlD
Ticlopidine—CYP2C8—female reproductive system—breast cancer	0.000143	0.0188	CbGeAlD
Ticlopidine—MPO—lymph node—breast cancer	0.000143	0.0188	CbGeAlD
Ticlopidine—CYP2C19—endocrine gland—breast cancer	0.000139	0.0182	CbGeAlD
Ticlopidine—CYP1A1—female reproductive system—breast cancer	0.000132	0.0174	CbGeAlD
Ticlopidine—CYP2B6—female reproductive system—breast cancer	0.000129	0.0169	CbGeAlD
Ticlopidine—CYP2C9—female reproductive system—breast cancer	0.000127	0.0167	CbGeAlD
Ticlopidine—CYP2B6—adrenal gland—breast cancer	0.000126	0.0165	CbGeAlD
Ticlopidine—CYP2C8—endocrine gland—breast cancer	0.000121	0.0159	CbGeAlD
Ticlopidine—CYP2E1—female reproductive system—breast cancer	0.000121	0.0158	CbGeAlD
Ticlopidine—CYP1A1—female gonad—breast cancer	0.00012	0.0158	CbGeAlD
Ticlopidine—CYP2E1—adrenal gland—breast cancer	0.000118	0.0155	CbGeAlD
Ticlopidine—CYP1A2—endocrine gland—breast cancer	0.000114	0.0149	CbGeAlD
Ticlopidine—CYP1A1—endocrine gland—breast cancer	0.000112	0.0147	CbGeAlD
Ticlopidine—CYP2B6—endocrine gland—breast cancer	0.000109	0.0143	CbGeAlD
Ticlopidine—CYP2C9—endocrine gland—breast cancer	0.000108	0.0141	CbGeAlD
Ticlopidine—CYP2E1—endocrine gland—breast cancer	0.000102	0.0134	CbGeAlD
Ticlopidine—CYP3A4—female reproductive system—breast cancer	9.71e-05	0.0127	CbGeAlD
Ticlopidine—CYP2D6—female reproductive system—breast cancer	9.56e-05	0.0125	CbGeAlD
Ticlopidine—CYP2D6—female gonad—breast cancer	8.7e-05	0.0114	CbGeAlD
Ticlopidine—CYP3A4—endocrine gland—breast cancer	8.22e-05	0.0108	CbGeAlD
Ticlopidine—CYP2D6—endocrine gland—breast cancer	8.09e-05	0.0106	CbGeAlD
Ticlopidine—CYP1A1—lymph node—breast cancer	7.74e-05	0.0102	CbGeAlD
Ticlopidine—Eosinophilia—Methotrexate—breast cancer	7.55e-05	0.000558	CcSEcCtD
Ticlopidine—Nausea—Vinblastine—breast cancer	7.54e-05	0.000557	CcSEcCtD
Ticlopidine—Vomiting—Goserelin—breast cancer	7.49e-05	0.000554	CcSEcCtD
Ticlopidine—Pruritus—Vinorelbine—breast cancer	7.47e-05	0.000552	CcSEcCtD
Ticlopidine—Pain—Irinotecan—breast cancer	7.44e-05	0.00055	CcSEcCtD
Ticlopidine—Pain—Mitoxantrone—breast cancer	7.44e-05	0.00055	CcSEcCtD
Ticlopidine—Rash—Goserelin—breast cancer	7.43e-05	0.000549	CcSEcCtD
Ticlopidine—Hypersensitivity—Thiotepa—breast cancer	7.43e-05	0.000549	CcSEcCtD
Ticlopidine—Dermatitis—Goserelin—breast cancer	7.42e-05	0.000548	CcSEcCtD
Ticlopidine—Arthralgia—Paclitaxel—breast cancer	7.41e-05	0.000547	CcSEcCtD
Ticlopidine—Myalgia—Paclitaxel—breast cancer	7.41e-05	0.000547	CcSEcCtD
Ticlopidine—Headache—Goserelin—breast cancer	7.38e-05	0.000545	CcSEcCtD
Ticlopidine—Decreased appetite—Gemcitabine—breast cancer	7.37e-05	0.000545	CcSEcCtD
Ticlopidine—Dyspepsia—Fluorouracil—breast cancer	7.34e-05	0.000542	CcSEcCtD
Ticlopidine—Nausea—Tamoxifen—breast cancer	7.33e-05	0.000541	CcSEcCtD
Ticlopidine—Pain—Gemcitabine—breast cancer	7.25e-05	0.000536	CcSEcCtD
Ticlopidine—Decreased appetite—Fluorouracil—breast cancer	7.25e-05	0.000535	CcSEcCtD
Ticlopidine—Pancytopenia—Methotrexate—breast cancer	7.24e-05	0.000535	CcSEcCtD
Ticlopidine—Asthenia—Thiotepa—breast cancer	7.23e-05	0.000534	CcSEcCtD
Ticlopidine—Diarrhoea—Vinorelbine—breast cancer	7.22e-05	0.000534	CcSEcCtD
Ticlopidine—Abdominal distension—Epirubicin—breast cancer	7.19e-05	0.000531	CcSEcCtD
Ticlopidine—Nausea—Melphalan—breast cancer	7.18e-05	0.00053	CcSEcCtD
Ticlopidine—Pruritus—Thiotepa—breast cancer	7.13e-05	0.000527	CcSEcCtD
Ticlopidine—Pain—Fluorouracil—breast cancer	7.13e-05	0.000527	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Mitoxantrone—breast cancer	7.12e-05	0.000526	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Irinotecan—breast cancer	7.12e-05	0.000526	CcSEcCtD
Ticlopidine—Anaphylactic shock—Paclitaxel—breast cancer	7.1e-05	0.000525	CcSEcCtD
Ticlopidine—Muscle spasms—Docetaxel—breast cancer	7.09e-05	0.000524	CcSEcCtD
Ticlopidine—Eosinophilia—Epirubicin—breast cancer	7.07e-05	0.000522	CcSEcCtD
Ticlopidine—Liver function test abnormal—Doxorubicin—breast cancer	7.05e-05	0.000521	CcSEcCtD
Ticlopidine—Flatulence—Capecitabine—breast cancer	7.03e-05	0.00052	CcSEcCtD
Ticlopidine—Nausea—Goserelin—breast cancer	7e-05	0.000517	CcSEcCtD
Ticlopidine—Dizziness—Vinorelbine—breast cancer	6.98e-05	0.000516	CcSEcCtD
Ticlopidine—Thrombocytopenia—Paclitaxel—breast cancer	6.95e-05	0.000514	CcSEcCtD
Ticlopidine—Urticaria—Mitoxantrone—breast cancer	6.92e-05	0.000511	CcSEcCtD
Ticlopidine—Diarrhoea—Thiotepa—breast cancer	6.9e-05	0.00051	CcSEcCtD
Ticlopidine—Body temperature increased—Irinotecan—breast cancer	6.88e-05	0.000508	CcSEcCtD
Ticlopidine—Body temperature increased—Mitoxantrone—breast cancer	6.88e-05	0.000508	CcSEcCtD
Ticlopidine—Muscle spasms—Capecitabine—breast cancer	6.86e-05	0.000507	CcSEcCtD
Ticlopidine—Pancytopenia—Epirubicin—breast cancer	6.78e-05	0.000501	CcSEcCtD
Ticlopidine—Anorexia—Paclitaxel—breast cancer	6.77e-05	0.0005	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Methotrexate—breast cancer	6.74e-05	0.000498	CcSEcCtD
Ticlopidine—Vomiting—Vinorelbine—breast cancer	6.71e-05	0.000496	CcSEcCtD
Ticlopidine—Body temperature increased—Gemcitabine—breast cancer	6.7e-05	0.000495	CcSEcCtD
Ticlopidine—Renal failure—Methotrexate—breast cancer	6.68e-05	0.000494	CcSEcCtD
Ticlopidine—Dizziness—Thiotepa—breast cancer	6.67e-05	0.000492	CcSEcCtD
Ticlopidine—Rash—Vinorelbine—breast cancer	6.65e-05	0.000492	CcSEcCtD
Ticlopidine—Dermatitis—Vinorelbine—breast cancer	6.65e-05	0.000491	CcSEcCtD
Ticlopidine—Abdominal distension—Doxorubicin—breast cancer	6.65e-05	0.000491	CcSEcCtD
Ticlopidine—Urticaria—Fluorouracil—breast cancer	6.62e-05	0.000489	CcSEcCtD
Ticlopidine—Headache—Vinorelbine—breast cancer	6.61e-05	0.000489	CcSEcCtD
Ticlopidine—Body temperature increased—Fluorouracil—breast cancer	6.59e-05	0.000487	CcSEcCtD
Ticlopidine—Eosinophilia—Doxorubicin—breast cancer	6.54e-05	0.000483	CcSEcCtD
Ticlopidine—Haematuria—Methotrexate—breast cancer	6.48e-05	0.000479	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Paclitaxel—breast cancer	6.47e-05	0.000478	CcSEcCtD
Ticlopidine—Epistaxis—Methotrexate—breast cancer	6.41e-05	0.000474	CcSEcCtD
Ticlopidine—Hypersensitivity—Mitoxantrone—breast cancer	6.41e-05	0.000474	CcSEcCtD
Ticlopidine—Hypersensitivity—Irinotecan—breast cancer	6.41e-05	0.000474	CcSEcCtD
Ticlopidine—Vomiting—Thiotepa—breast cancer	6.41e-05	0.000474	CcSEcCtD
Ticlopidine—Rash—Thiotepa—breast cancer	6.36e-05	0.00047	CcSEcCtD
Ticlopidine—Dermatitis—Thiotepa—breast cancer	6.35e-05	0.000469	CcSEcCtD
Ticlopidine—Headache—Thiotepa—breast cancer	6.31e-05	0.000467	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Epirubicin—breast cancer	6.31e-05	0.000466	CcSEcCtD
Ticlopidine—Myalgia—Docetaxel—breast cancer	6.28e-05	0.000464	CcSEcCtD
Ticlopidine—Arthralgia—Docetaxel—breast cancer	6.28e-05	0.000464	CcSEcCtD
Ticlopidine—Pancytopenia—Doxorubicin—breast cancer	6.27e-05	0.000463	CcSEcCtD
Ticlopidine—Nausea—Vinorelbine—breast cancer	6.27e-05	0.000463	CcSEcCtD
Ticlopidine—Renal failure—Epirubicin—breast cancer	6.26e-05	0.000462	CcSEcCtD
Ticlopidine—Dyspepsia—Paclitaxel—breast cancer	6.25e-05	0.000462	CcSEcCtD
Ticlopidine—Asthenia—Irinotecan—breast cancer	6.25e-05	0.000461	CcSEcCtD
Ticlopidine—Asthenia—Mitoxantrone—breast cancer	6.25e-05	0.000461	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Epirubicin—breast cancer	6.24e-05	0.000461	CcSEcCtD
Ticlopidine—Decreased appetite—Paclitaxel—breast cancer	6.17e-05	0.000456	CcSEcCtD
Ticlopidine—Hypersensitivity—Fluorouracil—breast cancer	6.14e-05	0.000454	CcSEcCtD
Ticlopidine—Haemoglobin—Methotrexate—breast cancer	6.14e-05	0.000453	CcSEcCtD
Ticlopidine—Hepatitis—Methotrexate—breast cancer	6.1e-05	0.000451	CcSEcCtD
Ticlopidine—Haemorrhage—Methotrexate—breast cancer	6.1e-05	0.000451	CcSEcCtD
Ticlopidine—Asthenia—Gemcitabine—breast cancer	6.08e-05	0.000449	CcSEcCtD
Ticlopidine—Arthralgia—Capecitabine—breast cancer	6.08e-05	0.000449	CcSEcCtD
Ticlopidine—Myalgia—Capecitabine—breast cancer	6.08e-05	0.000449	CcSEcCtD
Ticlopidine—Pain—Paclitaxel—breast cancer	6.07e-05	0.000449	CcSEcCtD
Ticlopidine—Haematuria—Epirubicin—breast cancer	6.07e-05	0.000448	CcSEcCtD
Ticlopidine—Anaphylactic shock—Docetaxel—breast cancer	6.02e-05	0.000445	CcSEcCtD
Ticlopidine—Epistaxis—Epirubicin—breast cancer	6e-05	0.000443	CcSEcCtD
Ticlopidine—Pruritus—Gemcitabine—breast cancer	6e-05	0.000443	CcSEcCtD
Ticlopidine—Nausea—Thiotepa—breast cancer	5.99e-05	0.000442	CcSEcCtD
Ticlopidine—Diarrhoea—Irinotecan—breast cancer	5.96e-05	0.00044	CcSEcCtD
Ticlopidine—Diarrhoea—Mitoxantrone—breast cancer	5.96e-05	0.00044	CcSEcCtD
Ticlopidine—Pruritus—Fluorouracil—breast cancer	5.9e-05	0.000436	CcSEcCtD
Ticlopidine—Thrombocytopenia—Docetaxel—breast cancer	5.89e-05	0.000435	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Doxorubicin—breast cancer	5.84e-05	0.000431	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Paclitaxel—breast cancer	5.81e-05	0.000429	CcSEcCtD
Ticlopidine—Diarrhoea—Gemcitabine—breast cancer	5.8e-05	0.000429	CcSEcCtD
Ticlopidine—Renal failure—Doxorubicin—breast cancer	5.79e-05	0.000428	CcSEcCtD
Ticlopidine—Erythema multiforme—Methotrexate—breast cancer	5.77e-05	0.000426	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Doxorubicin—breast cancer	5.77e-05	0.000426	CcSEcCtD
Ticlopidine—Dizziness—Irinotecan—breast cancer	5.76e-05	0.000425	CcSEcCtD
Ticlopidine—Haemoglobin—Epirubicin—breast cancer	5.74e-05	0.000424	CcSEcCtD
Ticlopidine—Anorexia—Docetaxel—breast cancer	5.74e-05	0.000424	CcSEcCtD
Ticlopidine—Hepatitis—Epirubicin—breast cancer	5.71e-05	0.000422	CcSEcCtD
Ticlopidine—Haemorrhage—Epirubicin—breast cancer	5.71e-05	0.000422	CcSEcCtD
Ticlopidine—Diarrhoea—Fluorouracil—breast cancer	5.7e-05	0.000421	CcSEcCtD
Ticlopidine—Thrombocytopenia—Capecitabine—breast cancer	5.7e-05	0.000421	CcSEcCtD
Ticlopidine—Tinnitus—Methotrexate—breast cancer	5.69e-05	0.000421	CcSEcCtD
Ticlopidine—Urticaria—Paclitaxel—breast cancer	5.64e-05	0.000417	CcSEcCtD
Ticlopidine—Haematuria—Doxorubicin—breast cancer	5.61e-05	0.000415	CcSEcCtD
Ticlopidine—Body temperature increased—Paclitaxel—breast cancer	5.61e-05	0.000415	CcSEcCtD
Ticlopidine—Epistaxis—Doxorubicin—breast cancer	5.55e-05	0.00041	CcSEcCtD
Ticlopidine—Anorexia—Capecitabine—breast cancer	5.55e-05	0.00041	CcSEcCtD
Ticlopidine—Vomiting—Irinotecan—breast cancer	5.53e-05	0.000409	CcSEcCtD
Ticlopidine—Vomiting—Mitoxantrone—breast cancer	5.53e-05	0.000409	CcSEcCtD
Ticlopidine—Dizziness—Fluorouracil—breast cancer	5.51e-05	0.000407	CcSEcCtD
Ticlopidine—Rash—Mitoxantrone—breast cancer	5.49e-05	0.000406	CcSEcCtD
Ticlopidine—Rash—Irinotecan—breast cancer	5.49e-05	0.000406	CcSEcCtD
Ticlopidine—Dermatitis—Irinotecan—breast cancer	5.48e-05	0.000405	CcSEcCtD
Ticlopidine—Dermatitis—Mitoxantrone—breast cancer	5.48e-05	0.000405	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Docetaxel—breast cancer	5.48e-05	0.000405	CcSEcCtD
Ticlopidine—Headache—Mitoxantrone—breast cancer	5.45e-05	0.000403	CcSEcCtD
Ticlopidine—Headache—Irinotecan—breast cancer	5.45e-05	0.000403	CcSEcCtD
Ticlopidine—Erythema multiforme—Epirubicin—breast cancer	5.4e-05	0.000399	CcSEcCtD
Ticlopidine—Vomiting—Gemcitabine—breast cancer	5.39e-05	0.000398	CcSEcCtD
Ticlopidine—Rash—Gemcitabine—breast cancer	5.35e-05	0.000395	CcSEcCtD
Ticlopidine—Dermatitis—Gemcitabine—breast cancer	5.34e-05	0.000395	CcSEcCtD
Ticlopidine—Tinnitus—Epirubicin—breast cancer	5.33e-05	0.000394	CcSEcCtD
Ticlopidine—Haemoglobin—Doxorubicin—breast cancer	5.31e-05	0.000393	CcSEcCtD
Ticlopidine—Headache—Gemcitabine—breast cancer	5.31e-05	0.000392	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Capecitabine—breast cancer	5.31e-05	0.000392	CcSEcCtD
Ticlopidine—Vomiting—Fluorouracil—breast cancer	5.3e-05	0.000392	CcSEcCtD
Ticlopidine—Dyspepsia—Docetaxel—breast cancer	5.3e-05	0.000391	CcSEcCtD
Ticlopidine—Hepatitis—Doxorubicin—breast cancer	5.29e-05	0.000391	CcSEcCtD
Ticlopidine—Haemorrhage—Doxorubicin—breast cancer	5.29e-05	0.000391	CcSEcCtD
Ticlopidine—Rash—Fluorouracil—breast cancer	5.26e-05	0.000388	CcSEcCtD
Ticlopidine—Dermatitis—Fluorouracil—breast cancer	5.25e-05	0.000388	CcSEcCtD
Ticlopidine—Decreased appetite—Docetaxel—breast cancer	5.23e-05	0.000386	CcSEcCtD
Ticlopidine—Hypersensitivity—Paclitaxel—breast cancer	5.23e-05	0.000386	CcSEcCtD
Ticlopidine—Headache—Fluorouracil—breast cancer	5.22e-05	0.000386	CcSEcCtD
Ticlopidine—Nausea—Mitoxantrone—breast cancer	5.17e-05	0.000382	CcSEcCtD
Ticlopidine—Nausea—Irinotecan—breast cancer	5.17e-05	0.000382	CcSEcCtD
Ticlopidine—Pain—Docetaxel—breast cancer	5.15e-05	0.00038	CcSEcCtD
Ticlopidine—Dyspepsia—Capecitabine—breast cancer	5.13e-05	0.000379	CcSEcCtD
Ticlopidine—Asthenia—Paclitaxel—breast cancer	5.09e-05	0.000376	CcSEcCtD
Ticlopidine—Decreased appetite—Capecitabine—breast cancer	5.06e-05	0.000374	CcSEcCtD
Ticlopidine—Nausea—Gemcitabine—breast cancer	5.04e-05	0.000372	CcSEcCtD
Ticlopidine—Pruritus—Paclitaxel—breast cancer	5.02e-05	0.000371	CcSEcCtD
Ticlopidine—Erythema multiforme—Doxorubicin—breast cancer	5e-05	0.000369	CcSEcCtD
Ticlopidine—Pain—Capecitabine—breast cancer	4.98e-05	0.000368	CcSEcCtD
Ticlopidine—Nausea—Fluorouracil—breast cancer	4.95e-05	0.000366	CcSEcCtD
Ticlopidine—Tinnitus—Doxorubicin—breast cancer	4.93e-05	0.000364	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Docetaxel—breast cancer	4.92e-05	0.000364	CcSEcCtD
Ticlopidine—Flatulence—Epirubicin—breast cancer	4.9e-05	0.000362	CcSEcCtD
Ticlopidine—Diarrhoea—Paclitaxel—breast cancer	4.86e-05	0.000359	CcSEcCtD
Ticlopidine—Muscle spasms—Epirubicin—breast cancer	4.78e-05	0.000353	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Capecitabine—breast cancer	4.76e-05	0.000352	CcSEcCtD
Ticlopidine—Body temperature increased—Docetaxel—breast cancer	4.76e-05	0.000351	CcSEcCtD
Ticlopidine—Dizziness—Paclitaxel—breast cancer	4.69e-05	0.000347	CcSEcCtD
Ticlopidine—Urticaria—Capecitabine—breast cancer	4.63e-05	0.000342	CcSEcCtD
Ticlopidine—Body temperature increased—Capecitabine—breast cancer	4.61e-05	0.00034	CcSEcCtD
Ticlopidine—Flatulence—Doxorubicin—breast cancer	4.53e-05	0.000335	CcSEcCtD
Ticlopidine—Arthralgia—Methotrexate—breast cancer	4.52e-05	0.000334	CcSEcCtD
Ticlopidine—Myalgia—Methotrexate—breast cancer	4.52e-05	0.000334	CcSEcCtD
Ticlopidine—Vomiting—Paclitaxel—breast cancer	4.51e-05	0.000333	CcSEcCtD
Ticlopidine—Rash—Paclitaxel—breast cancer	4.48e-05	0.000331	CcSEcCtD
Ticlopidine—Dermatitis—Paclitaxel—breast cancer	4.47e-05	0.00033	CcSEcCtD
Ticlopidine—Headache—Paclitaxel—breast cancer	4.45e-05	0.000329	CcSEcCtD
Ticlopidine—Hypersensitivity—Docetaxel—breast cancer	4.43e-05	0.000328	CcSEcCtD
Ticlopidine—Muscle spasms—Doxorubicin—breast cancer	4.42e-05	0.000327	CcSEcCtD
Ticlopidine—Anaphylactic shock—Methotrexate—breast cancer	4.34e-05	0.00032	CcSEcCtD
Ticlopidine—Asthenia—Docetaxel—breast cancer	4.32e-05	0.000319	CcSEcCtD
Ticlopidine—Hypersensitivity—Capecitabine—breast cancer	4.29e-05	0.000317	CcSEcCtD
Ticlopidine—Pruritus—Docetaxel—breast cancer	4.26e-05	0.000315	CcSEcCtD
Ticlopidine—Thrombocytopenia—Methotrexate—breast cancer	4.25e-05	0.000314	CcSEcCtD
Ticlopidine—Arthralgia—Epirubicin—breast cancer	4.23e-05	0.000313	CcSEcCtD
Ticlopidine—Myalgia—Epirubicin—breast cancer	4.23e-05	0.000313	CcSEcCtD
Ticlopidine—Nausea—Paclitaxel—breast cancer	4.22e-05	0.000312	CcSEcCtD
Ticlopidine—Asthenia—Capecitabine—breast cancer	4.18e-05	0.000309	CcSEcCtD
Ticlopidine—Anorexia—Methotrexate—breast cancer	4.13e-05	0.000305	CcSEcCtD
Ticlopidine—Pruritus—Capecitabine—breast cancer	4.12e-05	0.000305	CcSEcCtD
Ticlopidine—Diarrhoea—Docetaxel—breast cancer	4.12e-05	0.000304	CcSEcCtD
Ticlopidine—Anaphylactic shock—Epirubicin—breast cancer	4.06e-05	0.0003	CcSEcCtD
Ticlopidine—Diarrhoea—Capecitabine—breast cancer	3.99e-05	0.000295	CcSEcCtD
Ticlopidine—Dizziness—Docetaxel—breast cancer	3.98e-05	0.000294	CcSEcCtD
Ticlopidine—Thrombocytopenia—Epirubicin—breast cancer	3.97e-05	0.000294	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Methotrexate—breast cancer	3.95e-05	0.000292	CcSEcCtD
Ticlopidine—Myalgia—Doxorubicin—breast cancer	3.92e-05	0.000289	CcSEcCtD
Ticlopidine—Arthralgia—Doxorubicin—breast cancer	3.92e-05	0.000289	CcSEcCtD
Ticlopidine—Anorexia—Epirubicin—breast cancer	3.87e-05	0.000286	CcSEcCtD
Ticlopidine—Dizziness—Capecitabine—breast cancer	3.85e-05	0.000285	CcSEcCtD
Ticlopidine—Vomiting—Docetaxel—breast cancer	3.83e-05	0.000283	CcSEcCtD
Ticlopidine—Dyspepsia—Methotrexate—breast cancer	3.82e-05	0.000282	CcSEcCtD
Ticlopidine—Rash—Docetaxel—breast cancer	3.79e-05	0.00028	CcSEcCtD
Ticlopidine—Dermatitis—Docetaxel—breast cancer	3.79e-05	0.00028	CcSEcCtD
Ticlopidine—Decreased appetite—Methotrexate—breast cancer	3.77e-05	0.000279	CcSEcCtD
Ticlopidine—Headache—Docetaxel—breast cancer	3.77e-05	0.000279	CcSEcCtD
Ticlopidine—Anaphylactic shock—Doxorubicin—breast cancer	3.76e-05	0.000277	CcSEcCtD
Ticlopidine—Pain—Methotrexate—breast cancer	3.71e-05	0.000274	CcSEcCtD
Ticlopidine—Vomiting—Capecitabine—breast cancer	3.7e-05	0.000274	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Epirubicin—breast cancer	3.7e-05	0.000273	CcSEcCtD
Ticlopidine—Thrombocytopenia—Doxorubicin—breast cancer	3.68e-05	0.000272	CcSEcCtD
Ticlopidine—Rash—Capecitabine—breast cancer	3.67e-05	0.000271	CcSEcCtD
Ticlopidine—Dermatitis—Capecitabine—breast cancer	3.67e-05	0.000271	CcSEcCtD
Ticlopidine—Headache—Capecitabine—breast cancer	3.65e-05	0.00027	CcSEcCtD
Ticlopidine—Anorexia—Doxorubicin—breast cancer	3.58e-05	0.000264	CcSEcCtD
Ticlopidine—Nausea—Docetaxel—breast cancer	3.57e-05	0.000264	CcSEcCtD
Ticlopidine—Dyspepsia—Epirubicin—breast cancer	3.57e-05	0.000264	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Methotrexate—breast cancer	3.55e-05	0.000262	CcSEcCtD
Ticlopidine—Decreased appetite—Epirubicin—breast cancer	3.53e-05	0.000261	CcSEcCtD
Ticlopidine—Pain—Epirubicin—breast cancer	3.47e-05	0.000256	CcSEcCtD
Ticlopidine—Nausea—Capecitabine—breast cancer	3.46e-05	0.000256	CcSEcCtD
Ticlopidine—Urticaria—Methotrexate—breast cancer	3.45e-05	0.000255	CcSEcCtD
Ticlopidine—Body temperature increased—Methotrexate—breast cancer	3.43e-05	0.000253	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.42e-05	0.000253	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Epirubicin—breast cancer	3.32e-05	0.000245	CcSEcCtD
Ticlopidine—Dyspepsia—Doxorubicin—breast cancer	3.31e-05	0.000244	CcSEcCtD
Ticlopidine—Decreased appetite—Doxorubicin—breast cancer	3.26e-05	0.000241	CcSEcCtD
Ticlopidine—Urticaria—Epirubicin—breast cancer	3.22e-05	0.000238	CcSEcCtD
Ticlopidine—Pain—Doxorubicin—breast cancer	3.21e-05	0.000237	CcSEcCtD
Ticlopidine—Body temperature increased—Epirubicin—breast cancer	3.21e-05	0.000237	CcSEcCtD
Ticlopidine—Hypersensitivity—Methotrexate—breast cancer	3.2e-05	0.000236	CcSEcCtD
Ticlopidine—Asthenia—Methotrexate—breast cancer	3.11e-05	0.00023	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Doxorubicin—breast cancer	3.07e-05	0.000227	CcSEcCtD
Ticlopidine—Pruritus—Methotrexate—breast cancer	3.07e-05	0.000227	CcSEcCtD
Ticlopidine—Hypersensitivity—Epirubicin—breast cancer	2.99e-05	0.000221	CcSEcCtD
Ticlopidine—Urticaria—Doxorubicin—breast cancer	2.98e-05	0.00022	CcSEcCtD
Ticlopidine—Body temperature increased—Doxorubicin—breast cancer	2.97e-05	0.000219	CcSEcCtD
Ticlopidine—Diarrhoea—Methotrexate—breast cancer	2.97e-05	0.000219	CcSEcCtD
Ticlopidine—Asthenia—Epirubicin—breast cancer	2.91e-05	0.000215	CcSEcCtD
Ticlopidine—Pruritus—Epirubicin—breast cancer	2.87e-05	0.000212	CcSEcCtD
Ticlopidine—Dizziness—Methotrexate—breast cancer	2.87e-05	0.000212	CcSEcCtD
Ticlopidine—Diarrhoea—Epirubicin—breast cancer	2.78e-05	0.000205	CcSEcCtD
Ticlopidine—Hypersensitivity—Doxorubicin—breast cancer	2.77e-05	0.000204	CcSEcCtD
Ticlopidine—Vomiting—Methotrexate—breast cancer	2.76e-05	0.000204	CcSEcCtD
Ticlopidine—Rash—Methotrexate—breast cancer	2.73e-05	0.000202	CcSEcCtD
Ticlopidine—Dermatitis—Methotrexate—breast cancer	2.73e-05	0.000202	CcSEcCtD
Ticlopidine—Headache—Methotrexate—breast cancer	2.72e-05	0.000201	CcSEcCtD
Ticlopidine—Asthenia—Doxorubicin—breast cancer	2.69e-05	0.000199	CcSEcCtD
Ticlopidine—Dizziness—Epirubicin—breast cancer	2.68e-05	0.000198	CcSEcCtD
Ticlopidine—Pruritus—Doxorubicin—breast cancer	2.66e-05	0.000196	CcSEcCtD
Ticlopidine—Vomiting—Epirubicin—breast cancer	2.58e-05	0.000191	CcSEcCtD
Ticlopidine—Nausea—Methotrexate—breast cancer	2.58e-05	0.00019	CcSEcCtD
Ticlopidine—Diarrhoea—Doxorubicin—breast cancer	2.57e-05	0.00019	CcSEcCtD
Ticlopidine—Rash—Epirubicin—breast cancer	2.56e-05	0.000189	CcSEcCtD
Ticlopidine—Dermatitis—Epirubicin—breast cancer	2.56e-05	0.000189	CcSEcCtD
Ticlopidine—Headache—Epirubicin—breast cancer	2.54e-05	0.000188	CcSEcCtD
Ticlopidine—Dizziness—Doxorubicin—breast cancer	2.48e-05	0.000183	CcSEcCtD
Ticlopidine—Nausea—Epirubicin—breast cancer	2.41e-05	0.000178	CcSEcCtD
Ticlopidine—Vomiting—Doxorubicin—breast cancer	2.39e-05	0.000176	CcSEcCtD
Ticlopidine—Rash—Doxorubicin—breast cancer	2.37e-05	0.000175	CcSEcCtD
Ticlopidine—Dermatitis—Doxorubicin—breast cancer	2.37e-05	0.000175	CcSEcCtD
Ticlopidine—Headache—Doxorubicin—breast cancer	2.35e-05	0.000174	CcSEcCtD
Ticlopidine—Nausea—Doxorubicin—breast cancer	2.23e-05	0.000165	CcSEcCtD
Ticlopidine—P2RY12—Signaling Pathways—HRAS—breast cancer	3.02e-06	3.46e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—HMOX1—breast cancer	3.01e-06	3.45e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—SLC2A1—breast cancer	3.01e-06	3.45e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—NQO1—breast cancer	3.01e-06	3.45e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ITPR1—breast cancer	3e-06	3.45e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—NCOA1—breast cancer	2.99e-06	3.43e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—NQO1—breast cancer	2.98e-06	3.42e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—SLC2A1—breast cancer	2.98e-06	3.42e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—STK11—breast cancer	2.95e-06	3.38e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP19A1—breast cancer	2.95e-06	3.38e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP3A4—breast cancer	2.93e-06	3.36e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GPX1—breast cancer	2.93e-06	3.36e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—MTHFR—breast cancer	2.93e-06	3.36e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.92e-06	3.35e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP3A4—breast cancer	2.91e-06	3.33e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP17A1—breast cancer	2.9e-06	3.33e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.89e-06	3.32e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ABCB1—breast cancer	2.89e-06	3.32e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—IL6—breast cancer	2.89e-06	3.31e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP1B1—breast cancer	2.88e-06	3.31e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ERCC2—breast cancer	2.88e-06	3.3e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ENO1—breast cancer	2.87e-06	3.29e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PTGS1—breast cancer	2.87e-06	3.29e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—MTHFR—breast cancer	2.87e-06	3.29e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.86e-06	3.28e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP1B1—breast cancer	2.86e-06	3.28e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—TYMS—breast cancer	2.84e-06	3.26e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—HSP90AA1—breast cancer	2.83e-06	3.24e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.82e-06	3.24e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP2D6—breast cancer	2.82e-06	3.23e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GSTM1—breast cancer	2.81e-06	3.22e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—NCOR1—breast cancer	2.81e-06	3.22e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PLA2G4A—breast cancer	2.81e-06	3.22e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.8e-06	3.21e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.76e-06	3.17e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NCOA2—breast cancer	2.76e-06	3.17e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—NCOA1—breast cancer	2.75e-06	3.15e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—COMT—breast cancer	2.74e-06	3.14e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GSTP1—breast cancer	2.73e-06	3.13e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—NCOA1—breast cancer	2.73e-06	3.13e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—STK11—breast cancer	2.71e-06	3.11e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP19A1—breast cancer	2.71e-06	3.11e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—MTHFR—breast cancer	2.7e-06	3.1e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CAV1—breast cancer	2.7e-06	3.1e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—HMOX1—breast cancer	2.69e-06	3.08e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GPX1—breast cancer	2.69e-06	3.08e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—STK11—breast cancer	2.69e-06	3.08e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP19A1—breast cancer	2.69e-06	3.08e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ITPR1—breast cancer	2.68e-06	3.08e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—FASN—breast cancer	2.68e-06	3.07e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—DPYD—breast cancer	2.67e-06	3.07e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—MED12—breast cancer	2.67e-06	3.07e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—BCHE—breast cancer	2.67e-06	3.06e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—AKT1—breast cancer	2.66e-06	3.06e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYP1A1—breast cancer	2.66e-06	3.05e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CAV1—breast cancer	2.65e-06	3.04e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ERCC2—breast cancer	2.64e-06	3.03e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—SLC5A5—breast cancer	2.64e-06	3.02e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ALDOA—breast cancer	2.63e-06	3.02e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ABCB1—breast cancer	2.58e-06	2.96e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NCOA3—breast cancer	2.56e-06	2.93e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—SLC2A1—breast cancer	2.55e-06	2.92e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NQO1—breast cancer	2.55e-06	2.92e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SLC2A2—breast cancer	2.54e-06	2.91e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—TYMS—breast cancer	2.53e-06	2.91e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.52e-06	2.89e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—COMT—breast cancer	2.52e-06	2.89e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GSTP1—breast cancer	2.51e-06	2.88e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.5e-06	2.87e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—NCOR1—breast cancer	2.5e-06	2.87e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GSTM1—breast cancer	2.5e-06	2.87e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—COMT—breast cancer	2.5e-06	2.86e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CAV1—breast cancer	2.49e-06	2.86e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.49e-06	2.86e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CPT1A—breast cancer	2.49e-06	2.85e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ABCG2—breast cancer	2.49e-06	2.85e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—MTR—breast cancer	2.49e-06	2.85e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GSTP1—breast cancer	2.49e-06	2.85e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP3A4—breast cancer	2.48e-06	2.85e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—MTHFR—breast cancer	2.48e-06	2.85e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—HMOX1—breast cancer	2.47e-06	2.84e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.47e-06	2.83e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ITPR1—breast cancer	2.47e-06	2.83e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CG—breast cancer	2.46e-06	2.82e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—HMOX1—breast cancer	2.45e-06	2.81e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ITPR1—breast cancer	2.45e-06	2.81e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP1B1—breast cancer	2.44e-06	2.8e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—HPGDS—breast cancer	2.44e-06	2.8e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—HBA1—breast cancer	2.42e-06	2.78e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CG—breast cancer	2.41e-06	2.77e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GPX1—breast cancer	2.4e-06	2.75e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—HSP90AA1—breast cancer	2.39e-06	2.75e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.38e-06	2.73e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP1A1—breast cancer	2.37e-06	2.72e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ABCB1—breast cancer	2.37e-06	2.72e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ACHE—breast cancer	2.36e-06	2.71e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTT1—breast cancer	2.36e-06	2.71e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ERCC2—breast cancer	2.35e-06	2.7e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ABCB1—breast cancer	2.35e-06	2.7e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—TYMS—breast cancer	2.33e-06	2.67e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NCOA1—breast cancer	2.33e-06	2.67e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—TYMS—breast cancer	2.31e-06	2.65e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—NCOR1—breast cancer	2.3e-06	2.64e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GSTM1—breast cancer	2.3e-06	2.64e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.3e-06	2.64e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—STK11—breast cancer	2.3e-06	2.63e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP19A1—breast cancer	2.3e-06	2.63e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CAV1—breast cancer	2.29e-06	2.62e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—NCOR1—breast cancer	2.28e-06	2.62e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.28e-06	2.62e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GSTM1—breast cancer	2.28e-06	2.62e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CG—breast cancer	2.27e-06	2.61e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP17A1—breast cancer	2.24e-06	2.57e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PTGS1—breast cancer	2.22e-06	2.54e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ENO1—breast cancer	2.22e-06	2.54e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—MTHFR—breast cancer	2.21e-06	2.54e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GPX1—breast cancer	2.21e-06	2.53e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GPX1—breast cancer	2.19e-06	2.51e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.19e-06	2.51e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP1A1—breast cancer	2.18e-06	2.51e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP2D6—breast cancer	2.17e-06	2.49e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ERCC2—breast cancer	2.17e-06	2.48e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP1A1—breast cancer	2.16e-06	2.48e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CD—breast cancer	2.16e-06	2.48e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.15e-06	2.47e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ERCC2—breast cancer	2.15e-06	2.46e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—ALB—breast cancer	2.14e-06	2.45e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—COMT—breast cancer	2.13e-06	2.45e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NCOA2—breast cancer	2.13e-06	2.45e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTP1—breast cancer	2.12e-06	2.44e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CD—breast cancer	2.12e-06	2.43e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—HMOX1—breast cancer	2.09e-06	2.4e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—ALB—breast cancer	2.09e-06	2.4e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ITPR1—breast cancer	2.09e-06	2.4e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CG—breast cancer	2.08e-06	2.39e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—FASN—breast cancer	2.07e-06	2.37e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—BCHE—breast cancer	2.06e-06	2.36e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—NOS3—breast cancer	2.04e-06	2.34e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CAV1—breast cancer	2.04e-06	2.34e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—MTHFR—breast cancer	2.04e-06	2.34e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SLC5A5—breast cancer	2.03e-06	2.33e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—MTHFR—breast cancer	2.02e-06	2.32e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ABCB1—breast cancer	2.01e-06	2.31e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—NOS3—breast cancer	2e-06	2.3e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CD—breast cancer	2e-06	2.29e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—TYMS—breast cancer	1.97e-06	2.27e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ALB—breast cancer	1.97e-06	2.26e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NQO1—breast cancer	1.96e-06	2.25e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SLC2A1—breast cancer	1.96e-06	2.25e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NCOR1—breast cancer	1.95e-06	2.24e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.95e-06	2.24e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTM1—breast cancer	1.95e-06	2.24e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.95e-06	2.24e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—NOS3—breast cancer	1.89e-06	2.16e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CB—breast cancer	1.89e-06	2.16e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP1B1—breast cancer	1.88e-06	2.16e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CAV1—breast cancer	1.88e-06	2.15e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GPX1—breast cancer	1.87e-06	2.14e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PTGS2—breast cancer	1.87e-06	2.14e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CAV1—breast cancer	1.86e-06	2.14e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CG—breast cancer	1.86e-06	2.13e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP1A1—breast cancer	1.85e-06	2.12e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.85e-06	2.12e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CB—breast cancer	1.85e-06	2.12e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ERCC2—breast cancer	1.83e-06	2.11e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CD—breast cancer	1.83e-06	2.1e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PTGS2—breast cancer	1.83e-06	2.1e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ALB—breast cancer	1.81e-06	2.07e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NCOA1—breast cancer	1.8e-06	2.06e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.78e-06	2.04e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP19A1—breast cancer	1.77e-06	2.03e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—STK11—breast cancer	1.77e-06	2.03e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CB—breast cancer	1.74e-06	2e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—NOS3—breast cancer	1.73e-06	1.98e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PTGS2—breast cancer	1.73e-06	1.98e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—MTHFR—breast cancer	1.72e-06	1.98e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CG—breast cancer	1.71e-06	1.96e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CG—breast cancer	1.7e-06	1.95e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—COMT—breast cancer	1.65e-06	1.89e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTP1—breast cancer	1.64e-06	1.88e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CD—breast cancer	1.63e-06	1.88e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PTEN—breast cancer	1.63e-06	1.87e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—HMOX1—breast cancer	1.62e-06	1.85e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ALB—breast cancer	1.61e-06	1.85e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ITPR1—breast cancer	1.61e-06	1.85e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CB—breast cancer	1.6e-06	1.83e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PTEN—breast cancer	1.6e-06	1.83e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CAV1—breast cancer	1.59e-06	1.83e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PTGS2—breast cancer	1.58e-06	1.81e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ABCB1—breast cancer	1.55e-06	1.78e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—NOS3—breast cancer	1.54e-06	1.77e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—TYMS—breast cancer	1.52e-06	1.75e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.52e-06	1.74e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTM1—breast cancer	1.51e-06	1.73e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NCOR1—breast cancer	1.51e-06	1.73e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.51e-06	1.73e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PTEN—breast cancer	1.5e-06	1.73e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.5e-06	1.73e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CD—breast cancer	1.49e-06	1.71e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ALB—breast cancer	1.48e-06	1.7e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ALB—breast cancer	1.47e-06	1.69e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CG—breast cancer	1.45e-06	1.66e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GPX1—breast cancer	1.44e-06	1.65e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP1A1—breast cancer	1.43e-06	1.64e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CB—breast cancer	1.42e-06	1.63e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—NOS3—breast cancer	1.42e-06	1.63e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ERCC2—breast cancer	1.42e-06	1.62e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PTGS2—breast cancer	1.41e-06	1.62e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—NOS3—breast cancer	1.41e-06	1.61e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PTEN—breast cancer	1.38e-06	1.58e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—MTHFR—breast cancer	1.33e-06	1.53e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.31e-06	1.5e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CB—breast cancer	1.3e-06	1.49e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PTGS2—breast cancer	1.3e-06	1.49e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PTGS2—breast cancer	1.29e-06	1.48e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CD—breast cancer	1.27e-06	1.46e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ALB—breast cancer	1.26e-06	1.44e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PTEN—breast cancer	1.23e-06	1.41e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CAV1—breast cancer	1.23e-06	1.41e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NOS3—breast cancer	1.2e-06	1.38e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CA—breast cancer	1.15e-06	1.32e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PTEN—breast cancer	1.13e-06	1.3e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CA—breast cancer	1.13e-06	1.29e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PTEN—breast cancer	1.12e-06	1.29e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CG—breast cancer	1.12e-06	1.28e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CB—breast cancer	1.11e-06	1.27e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PTGS2—breast cancer	1.1e-06	1.26e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CA—breast cancer	1.06e-06	1.22e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CD—breast cancer	9.83e-07	1.13e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CA—breast cancer	9.73e-07	1.12e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ALB—breast cancer	9.7e-07	1.11e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PTEN—breast cancer	9.59e-07	1.1e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—AKT1—breast cancer	9.39e-07	1.08e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NOS3—breast cancer	9.28e-07	1.07e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—AKT1—breast cancer	9.2e-07	1.06e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CA—breast cancer	8.69e-07	9.97e-06	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—AKT1—breast cancer	8.67e-07	9.95e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CB—breast cancer	8.57e-07	9.83e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PTGS2—breast cancer	8.49e-07	9.74e-06	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CA—breast cancer	7.99e-07	9.17e-06	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—AKT1—breast cancer	7.95e-07	9.12e-06	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CA—breast cancer	7.92e-07	9.09e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PTEN—breast cancer	7.4e-07	8.5e-06	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—AKT1—breast cancer	7.1e-07	8.14e-06	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CA—breast cancer	6.77e-07	7.77e-06	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—AKT1—breast cancer	6.53e-07	7.49e-06	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—AKT1—breast cancer	6.47e-07	7.42e-06	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—AKT1—breast cancer	5.53e-07	6.34e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CA—breast cancer	5.22e-07	5.99e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—AKT1—breast cancer	4.27e-07	4.9e-06	CbGpPWpGaD
